Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease-Reference-Cited by-同舟云学术

Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

Published:2019-05-15 Issue:1 Volume:11 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Siedlecki-Wullich Dolores,Català-Solsona Judit,Fábregas Cristina,Hernández Isabel,Clarimon Jordi,Lleó Alberto,Boada Merce,Saura Carlos A.,Rodríguez-Álvarez José^ORCID,Miñano-Molina Alfredo J.

Funder

Ministerio de Ciencia e Innovación

Fundació la Marató de TV3

Agència de Gestió d’Ajuts Universitaris i de Recerca

Centro Investigación Biomédica en red enfermedades neurodegenerativas

Departament de Salut, Generalitat de Catalunya

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-019-0501-4.pdf

Reference59 articles.

1. Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Götz J. Amyloid-β and tau complexity-towards improved biomarkers and targeted therapies. Nat Rev Neurol. 2018;14:22–39.

2. Honig LS, Vellas B, Woodward M, Boada M, Bullock R, Borrie M, et al. Trial of solanezumab for mild dementia due to Alzheimer’s disease. N Engl J Med. 2018;378:321–30.

3. Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, et al. Randomized trial of Verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2018;378:1691–703.

4. Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat Rev Neurol. 2015;11:41–55.

5. Blennow K, Mattsson N, Schöll M, Hansson O, Zetterberg H, et al. Amyloid biomarkers in Alzheimer’s disease. Trends Pharmacol Sci. 2015;36:297–309.

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the role of miRNAs in Alzheimer's disease: Predictive targeting and pathway modulation – A systematic review;Ageing Research Reviews;2024-11

2. Noncoding RNAs in Alzheimer’s Disease: Overview of Functional andTherapeutic Significance;Current Topics in Medicinal Chemistry;2024-07

3. Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity;International Journal of Biological Macromolecules;2024-06

4. Analysis of potential microRNA biomarkers for multiple sclerosis;Experimental and Molecular Pathology;2024-06

5. Unveiling the Complex Role of Exosomes in Alzheimer’s Disease;Journal of Inflammation Research;2024-06